Molecular differences in pancreatic cancer of Black and white patients identified

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies. The findings, which were recently published in the journal Cancer Research Communications, reinforce the need to include racially diverse participants in clinical studies.